MeiraGTx Holdings plc
$11.81
The Read: MeiraGTx historically reacts to regulatory catalysts with median absolute stock moves of about 36%, exemplified by surges of 31% to 121% driven by FDA Breakthrough Therapy Designations, positive clinical data, and strategic partnerships.
Price
Overlays
Panel
MGTX
Hover to view data
No Data